Form D · Pharmaceuticals
Niche Biopharmaceuticals LLC
Shorewood, MN · CIK 0001846144
Offering snapshot reported May 11, 2026 · SEC filing
- Reported sold
- $200K Offering amount: $200K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 20, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2026 | Initial | $200,000 | No comparison | 4 | SEC filing |
| May 9, 2025 | Initial | $100,000 | No comparison | 2 | SEC filing |
| Feb 6, 2023 | Initial | $200,000 | No comparison | 5 | SEC filing |
| Feb 17, 2021 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-583517
Source: Form D, filed May 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Brennan | Director |
| Robert Klem | Director |
| Dayton Reardan | Director, Executive, Promoter |
| Daniel Saccani | Director |
| Patrick Schlievert | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
22345 Bracketts Road
Shorewood, MN, 55331
Phone: 9524749628
Shorewood, MN, 55331
Phone: 9524749628